The genetic association between hyperthyroidism and heart failure: a Mendelian randomization study

Jun Liu1,2, Gujie Wu3, Shuqi Li2

  • 1Department of Health Management, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.

PubMed

Insights

This study establishes a genetic causal link between hyperthyroidism and an increased risk of heart failure. These findings suggest thyroid dysfunction may directly contribute to heart failure development.

Area of Science:

  • Endocrinology
  • Cardiology
  • Genetics

Background:

  • Hyperthyroidism is an endocrine disorder with diverse causes and symptoms.
  • Heart failure (HF) is a significant clinical condition with high morbidity and mortality.
  • While thyroid dysfunction is linked to heart disease, a causal relationship with HF remains unproven.

Purpose of the Study:

  • To investigate the potential causal relationship between hyperthyroidism and heart failure.
  • To explore the genetic basis of the association between hyperthyroidism and HF.

Main Methods:

  • Utilized two-sample Mendelian randomization (MR) analysis.
  • Employed summary data from a large genetic association study on hyperthyroidism.
  • Analyzed genetically determined all-cause heart failure data from the FinnGen Consortium (218,208 individuals).
  • Applied various statistical methods including inverse variance-weighted, weighted median, and MR-Egger.

Main Results:

  • Inverse variance-weighted analysis revealed a significant causal association between hyperthyroidism and increased risk of all-cause heart failure (OR=1.049, P=0.007).
  • Weighted median analysis corroborated this finding, showing a positive correlation (OR=1.049, P=0.044).
  • No significant horizontal pleiotropy or heterogeneity was detected, and leave-one-out analysis confirmed robustness.

Conclusions:

  • This study provides evidence for a causal relationship between hyperthyroidism and all-cause heart failure.
  • Genetic factors may underlie the association between hyperthyroidism and heart failure.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.4K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
564